Background: Increasingly, molecular genetic techniques are being used to improve our understanding of a number of common late onset complex disorders, such as hypertension, Alzheimer's disease' and noninsulin dependent diabetes mellitus7. Molecular genetic approaches have the potential to yield new information about disease pathogenesis that may be of great importance for the development of future treatments. Aims: This review discusses the evidence for a genetic contribution to the development of chronic obstructive pulmonary disease (COPD) and specifically focuses on the hypothesis that asthma and COPD share some pathogenic mechanisms as originally proposed in 1960 in a theory that has since become known as the Dutch Hypothesis.3 In particular we will review the evidence from molecular genetics, both in support of and against the theory.
1. Corder EH , Saunders AM , Strimater WJ et al. Gene dose apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families . Science1993; 261: 921-923 .
2.
2. Elbein SC . Perspective: the search for genes for type 2 diabetes in the post-genome era . Endocrinology2003; 143: 2012-2018 .
3.
3. Orie NGM , Sluiter JH , de Vries K et al. The host factor in bronchitis. In Bronchitis an international symposium, Springfield, IL: Charles C Thomas , 1961, 44-49.
4.
4. Corrigan CJ , Kay AB . T-cells and eosinophils in the pathogenesis of asthma . Immunol Today1992; 13: 501-507 .
5.
5. Crepea SB , Harman JW . The pathology of bronchial asthma . J Allergy1955; 26: 453-460 .
6.
6. Huber HL , Koessler KK . The pathology of bronchial asthma . Arch Intern Med1922; 30: 689-760 .
7.
7. Cardell BS , Pearson RSB . Death in asthmatics . Thorax1959; 4: 341-352 .
8.
8. Wright JL , Cagle P , Churg A et al. State of the art; disease of the small airways . Am Rev Respir Dis1992; 146: 240-262 .
9.
9. Barbee RA , Halonen M , Lebowitz MD et al. Distribution of IgE in a community population sample: correlation with age, sex, and skin test reactivity . JAllergy Clin Immunol1981; 68: 106-111 .
10.
10. Dow L , Coggon D , Campbell MJ et al. The interaction between Immunoglobulin E and smoking in airflow obstruction in the elderly . Am Rev Respir Dis1992; 146: 402-402 .
11.
11. Burrows B , Martinez F , Halonan M et al. Association of asthma with serum IgE levels and skin test reactivity to allergens . N Engl J Med1989; 20: 271-277 .
12.
12. Palmer LJ , Burton PR , Faux J et al. Independent inheritance of serum Immunoglobulin E and airway responsiveness . Am J Resp Crit Care Med2000; 161: 1836-1843 .
13.
13. Braman SS , Kaemerlen JT , Davis SM . Asthma in the elderly: a comparison between patients with recently acquired and long-standing disease . Am Rev Respir Dis1991; 143: 336-340 .
14.
14. Barbee RA , Halone M , Kaltenborn W et al. A longitudinal study of serum IgE in a community cohort: correlations with age, sex, smoking and atopic status . J Allergy Clin Immunol1987; 79: 919-927 .
15.
15. Vollmer WM , Buist SA , Johnson LR et al. Relationship between serum IgE and cross-sectional and longitudinal FEVI in two cohort studies . Chest1986; 90: 416-423 .
16.
16. Gerrard JW , Heiner DC , Ko CG et al. Immunoglobulin levels in smokers and non-smokers . Ann Allerg1980; 44: 261-262 .
17.
17. Burrows B , Halonen M , Barbee RA et al. The relationship of serum immunoglobulin E to cigarette smoking . Am Rev Respir Dis1981; 124: 523-525 .
18.
18. Pride NB , Vermiere P , Allegra L . Diagnostic labels applied to model case histories of chronic airflow obstruction. Responses to a questionnaire in 1 1 North American and Western European Countries . Eur Respir J1989; 2: 702-709 .
19.
19. Burrows B , Bloor JW , Traver GA et al. The course and prognosis of different forms of chronic airflow obstruction in a sample from the general population . N Engl J Med1987; 317: 1309-1314 .
20.
20. Lee HY , Stretton TB . Asthma in the elderly . Brit Med J1972; 4: 93-95 .
21.
21. Burr M , Charles T , Roy KL et al. Asthma in the elderly; an epidemiological survey . Brit Med J1979; 1(6170): 1041-1044 .
22.
22. Fletcher C , Peto R . The natural history of chronic airflow obstruction . Brit Med J1976; 1(6077): 1645-1648 .
23.
23. Fletcher C , Peto R , Tinker C et al. The natural history of chronic bronchitis: an eight year follow up study of working men in London. Oxford: Oxford University Press , 1976.
24.
24. Burrows B , Knudson RJ , Cline MG et al. Quantitative relationships between cigarette smoking and ventilatory function . Am Rev Respir Dis1977; 115: 195-205 .
25.
25. Louis PCA . Recherchs sur l'emphyseme des poumers . Meme Soc Med Obs1837; 1: 160-261 .
26.
26. Anonymous . BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS . Thorax1997; 52: S1-S28 .
27.
27. Brown PJ , Greville HW , Finucane KE . Asthma and irreversible airflow obstruction . Thorax1984; 39: 131-136 .
28.
28. Givelber RJ , Couropmitree NN , Gottleib DJ et al. Segregation analysis of pulmonary function among families in the Framingham Study . Am J Respir Crit Care Med1998; 157: 1445-1451 .
29.
29. Tager IB , Rosner B , Tishler PV et al. Household aggregation of pulmonary function and chronic bronchitis . Am Rev Respir Dis1976; 114: 485-492 .
30.
30. Chen Y , Home SL , Rennie DC et al. Segregation analysis of two lung function indices in a random sample of young families: the Humbolt Family Study . Genet Epidemiol1996; 13: 35-47 .
31.
31. Coultas DB , Hanis CL , Howard CA et al. Heritability of ventilatory function in smoking and non-smoking New Mexico Hispanics . Am Rev Respir Dis1991; 144: 770-775 .
32.
32. Larson RK , Barman ML , Kueppers et al. Genetic and environmental determinants of chronic obstructive pulmonary disease . Ann Int Med1970; 72: 627-632 .
33.
33. Cohen BH , Diamond EL , Graves GC . A common familial component in lung cancer and chronic obstructive pulmonary disease . Lancet1977; ii: 523-526 .
34.
34. Rybrick BA , Beaty TH , Cohen BH . Major genetic mechanism in pulmonary function . J Clin Epidemiol1990; 43: 667-675 .
35.
35. Sibbald B , Turner-Warwick M . Factors influencing the prevalence of asthma among first-degree relatives of extrinsic and intrinsic asthmatics . Thorax1979; 34: 332-337 .
36.
36. Ruse CE , Parker SG . Molecular genetics and age related disease . Age Ageing2001; 30: 449-454 .
37.
37. Daniels SE , Bhattacharrya S , James A . A genome wide search for quantitative trait loci underlying asthma . Nature1996; 383: 247-250 .
38.
38. CSGA . A genome-wide search for asthma susceptibility loci in ethnically diverse populations . Nature Genetics1997; 15: 389-392 .
39.
39. Ober C , Cox N , Parry R et al. Genome wide screen for asthma susceptibility loci in a founder population . Hum Molec Genet1998; 7: 1393-1393 .
40.
40. Wjst M , Fischer G , Immervoll T et al. A genome wide search for linkage to asthma . Genomics1999; 58: 1-8 .
41.
41. Diezer MH . Genome screen for asthma and related phenotypes in the French EGEA study . Am J Respir Crit Care Med2000; 162: 1812-1818 .
42.
42. Van Eerdewegh P , Little RD , Dupuis J et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness . Nature2002; 418: 426-430 .
43.
43. Silverman EK , Palmer LJMosley JD et al. Genome-wide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease . Am J Hum Genet2002; 70: 1229-1239 .
44.
44. Joost O , Wilk JB , Cupples LA et al. Genetic loci influencing lung function: a genome wide scan in the Framingham study . Am J Respir Crit Care Med2002; 165: 795-799 .
45.
45. Wilson AG , Symons JA , McDowell TL . Effects of a polymorphism in the human tumour necrosis factor gene on transcriptional activation . Proc Natl Acad Sci1997; 94: 391-399 .
46.
46. Louis E , Franchimont D , Piron A . Tumour necrosis factor gene polymorphism influences TNFa production in LPS stimulated whole blood cell culture in healthy humans . Clin Exp Immunol1998; 113: 401-406 .
47.
47. Kips JC , Tavemier JH , Joos GF . The potential role of tumour necrosis factor alpha in asthma . Clin Exp Allergy1993; 23: 247-250 .
48.
48. Keating VM , Collins, PD , Scott DP et al. Differences in IL-8 and TNF in induced sputum from patients with COPD or asthma . Am J Respir Crit Care Med1996; 152: 1646-1652 .
49.
49. I de Godoy , Donahoe M , Calhoun WJ . Elevated TNF alpha production by peripheral blood monocytes in weight losing COPD patients . Am J Respir Crit Care Med1996; 153: 633-637 .
51. Albuquerque RV , Hayden CM , Palmer LJ et al. Association of polymorphisms within the tumour necrosis factor (TNF) genes and childhood asthma . Clin Exp Allergy1998; 28: 578-584 .
52.
52. Huang SL , Su CH , Chang SC . Tumour necrosis factor gene polymorphism in chronic bronchitis . Am J Respir Crit Care Med1997; 156: 1436-1439 .
53.
53. Sakao S , Tatsumi K , Igari H et al. Association of TNFa gene promotor polymorphism with COPD . Am J Respir Crit Care Med2001; 163: 420-423 .
54.
54. Patuzzo C , Gile LS , Zorzetto M et al. Tumour necrosis factor gene complex in COPD and disseminated bronchiectasis . Chest2000; 117: 1353-1358 .
55.
55. Higham MA , Pride NB , Alikham A . Tumour necrosis polymorphism in chronic obstructive pulmonary disease . Eur Respir J2000; 15: 281-284 .
56.
56. Keating VM , Cave SJ , Henry M . A polymorphism in the TNF gene promoter region may predispose to a poor prognosis in patients with COPD . Chest2000; 118: 971-975 .
57.
57. Marsh DG , Neely JD , Breazeale DR et al. Linkage analysis of IL-4 and other chromosome 5q31.1 markers and total serum IgE concentrations . Science1994; 264: 1152-1156 .
58.
58. Postma D , Bleecker E , Amelung P et al. Genetic susceptibility to asthma-bronchial hyperresponsiveness co-inherited with a major gene for atopy . N Engl J Med1995; 337: 894-900 .
59.
59. Doull IJM , Lawrence S , Watson M et al. Allelic associations of gene markers on chromosome 5q and 1 lq with atopy and bronchial hyperresponsiveness . Am J Respir Crit Care Med1996; 153: 1280-1284 .
60.
60. Meyers DA , Postma, DS , Panhasysen CIM et al. Evidence for a locus regulating total serum IgE levels maps to chromosome 5 . Genomics1994; 23: 464-470 .
61.
61. Johnson M . Mechanisms of action of,B-adrenoceptor agonists. In Costello JF , Mann RD eds. Beta agonists in the treatment of asthma. Carnforith, UK: Parthenon , 1992: 27-42.
62.
62. Johnson M , Coleman RA . Mechanisms of action of beta-2-adrenoceptor agonists. In Busse WW , Holgate ST eds. Asthma and rhinitis. Cambridge, UK: Blackwell , 1995: 1276-1295.
63.
63. Chong LK , Chowdy J , Ghahramani et al. Influence of genetic polymorphisms in the beta-2-adrenoceptor on desensitisation in human mast cells . Pharmacogenetics2000; 10: 153-162 .
64.
64. Reihsaus E , Innis M , Maclntyre N et al. Mutations in the gene coding for the 3-2-adrenergic receptor in normal and asthmatic subjects . Am J Respir Cell Mol Biol1993; 8: 334-339 .
65.
65. Jacobs KB , Burton PR , Iyengar SK et al. Pooling data and linkage analysis in the chromosome 5q candidate region for asthma . Genet Epidemiol2001; Suppl 1: S103-S108 .
66.
66. Anthonisen NR , Wright EC , IPPB Trial Group . Bronchodilator response in chronic obstructive pulmonary disease . Am Rev Respir Dis1986; 133: 814-819 .
67.
67. Holloway JW , Dunbar PR , Riley GA et al. Association of beta adrenoceptor polymorphisms with severe asthma . Clin Exp Allergy2000; 30: 1097-1103 .
68.
68. Turki J , Pak J , Green SA et al. Genetic polymorphisms of the,32 adrenergic receptor in nocturnal and non-nocturnal asthma: evidence that Gly16 correlates with the nocturnal phenotype . J Clin Invest1995; 95: 1635-1641 .
69.
69. Weir TD , Mallek N , Sandford AJ et al. Beta-2-adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma . Am J Respir Crit Care Med1998; 158: 787-791 .
70.
70. Summerhill E , Leavitt SA , Gidley H et al. 3-2 adrenergic receptor argl6/argl6 is associated with reduced lung function, but not with asthma in the Hutterites . Am J Respir Crit Care Med2000; 162: 599-602 .
71.
71. Dewar J , Wheatley A , Ven A et al. Beta-2-adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with asthma in an adult population . Clin Exp Allergy1998; 28: 442-448 .
72.
72. Ho L , Ham HJ , Chen CJ et al. Polymorphism of the beta adrenoceptor in COPD in Chinese subjects . Chest2001; 120: 1493-1499 .
73.
73. Joos L , Weir TD , Connett JE , Anthonisen NR , Pare PD , Sandford AJ . Polymorphisms in the beta-2-adrenergic receptor and bronchodilator response, bronchial hyper-responsiviness, and rate of decline in lung function in smokers . Thorax2003; 58: 703-707 .
74.
74. Wills-Karpp M , Chiaramonte M , IL-13 in asthma . Curr Opin Pul Med2003; 9: 21-27 .
75.
75. Zheng T , Zhou Z , Wang Z et al. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase-and cathepsin-dependent emphysema . J Clin Invest2000; 106: 1081-1093 .
76.
76. Howard TD , Whittaker PA , Zaiman AL et al. Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population . Am J Respir Cell Mol Biol2001; 25: 377-384 .
77.
77. van de Pouw Krann TC , van Veen A , Boeije LC et al. An IL-13 promoter polymorphism associated with increased risk of allergic asthma . Genes Immunol1999; 1: 61-65 .
78.
78. He JQ , Connett JE , Anthonisen NR , Sandford AJ . Polymorphisms in the IL-13, IL-13 receptor and IL-4 receptor alpha genes and rate of decline of lung function in smokers . Am J Respir Cell Mol Biol2003; 28: 379-385 .
79.
79. Van der Pouw-Krann TC , Kucukagcon M , Bakker FM . COPD is associated with the-1055 promoter polymorphism . Genes Immunol2002; 3: 436-439 .
80.
80. Steine JW , Borish L . 11-4: its role in the pathogenesis of asthma and targeting it for asthma treatment with IL-4 receptor antagonists . Respir Res2001; 2: 66-70 .
81.
81. Kabesch M , Tzotcheva I , Carr D et al. A complete screening of the IL-4 gene: novel polymorphisms and their association with asthma . JAllergy Clin Immunol2003; 112: 893-898 .
82.
82. Beghe B , Barton S , Rorke S , Reng Q . Polymorphisms of the IL-4 and IL-4 receptor alpha chain genes confer susceptibility to asthma in a Caucasian population . Clin Exp Allergy2003; 33: 1111-1117 .
83.
83. Lensmar C , Nord M , Gudmundsson GH et al. Decreased pulmonary levels of the anti-inflammatory Clara cell 16 kDa protein after induction of airway inflammation in asthmatics . Cell Mol Life Sci2000; 57: 976-978 .
84.
84. Pilette C , Godding V , Kiss R et al. Reduced epithelial expression of secretory component in small airways correlates with airflow obstructionion COPD . Am J Respir Crit Care Med2001; 163: 185-194 .
85.
85. Laing IA , Hermans C , Bemard S , Burton PR , Glodblatt J , Le Souef PN . Association between plasma CC 16 levels, the A3C8G polymorphism and asthma . Am J Respir Crit Care Med2000; 161: 124-127 .
86.
86. Mansur AH , Fryer AA , Hepple M , Strange RC , Spiteris MA . An association study between the Clara cell secretory protein CC 16 A38G polymorphism and asthmatic phenotype . Clin Exp Allergy2002; 32: 994-999 .
87.
87. McLeod HL , Yu J . Cancer pharmacogenetics: SNPS, chips, and the individual patient . Cancer Invest2003; 21: 630-640 .
